(Press-News.org) Vancouver, British Columbia – Alzheimer's disease has been linked in many studies to amyloid plaque buildup in the brain, but new research is finding a common thread between amyloid burden and lower energy levels, or metabolism, of neurons in certain areas of the brain associated with Alzheimer's disease—even for people with no sign of cognitive decline. This is a new development in the understanding of Alzheimer's pathology, say neuroscientists unveiling the research at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.
"This study shows that there is an association between hypometabolism and amyloid in the brains of normal people," said Val J. Lowe, MD, a professor of radiology at Mayo Clinic Cancer Center based in Rochester, Minn. "Previous studies indicate that hypometabolism of this same pattern is present in patients who have abnormalities of the gene apolipoprotein E, or APOE. The hypothesis is that people who have these genetic abnormalities tend to have hypometabolism and are on the trajectory toward developing Alzheimer's disease. Hypometabolism does appear to be an early harbinger of the disease before dementia sets in."
The research is a part of a longitudinal multi-phase study called the Mayo Clinic Study of Aging, which includes 2,500 patients with 4,000 projected for the next phase. For this imaging study, 617 cognitively normal subjects underwent two separate positron emission tomography (PET) procedures, a molecular imaging technique that visualizes physiological processes in the body. Each subject was imaged with an amyloid-binding radionuclide imaging agent, C-11 Pittsburgh compound B (PiB), produced on-site at the Mayo Clinic. An hour later, all patients were imaged again using the same scanner and a different radionuclide agent, F-18 fluorodeoxyglucose (FDG), which shows up on scans as hot-and-cold spots according to metabolic brain cell activity.
Results were then analyzed via quantitative analysis and reviewed. Researchers found significant hypometabolism in brain regions classically associated with Alzheimer's disease, including the angular gyrus and posterior cingulate. Even the PiB PET scans that were deemed barely positive for amyloid were partnered with FDG PET scans that showed corresponding hypometabolism.
"In general, these findings were group-wide," said Lowe. "We now need to parse the data down to an individual subject level to see what is driving this relationship. As we follow these subjects long term, this relationship will be important because if people have amyloid in their brain and survive without Alzheimer's disease despite amyloid, we want to know why."
###
Scientific Paper 467: Val Lowe, Kejal Kantarci, Clifford Jack, Radiology, Mayo Clinic, Rochester, MN; David Knopman, Bradley Boeve, Ronald Petersen, Neurology, Mayo Clinic, Rochester, MN; Stephen Weigand, Matthew Senjem, Biostatistics, Mayo Clinic, Rochester, MN, "FDG changes in PiB positive, cognitively normal subjects," SNMMI's 60th Annual Meeting, June 8, 2013, Vancouver, British Columbia.
Pre-Alzheimer's: Metabolic disorder found in cognitively normal patients
Healthy test subjects with amyloid plaque were also found to have hypometabolism indicating a potential Alzheimer's precursor
2013-06-11
ELSE PRESS RELEASES FROM THIS DATE:
Molecular imaging finds hurdle for smokers' vaccine
2013-06-11
Vancouver, British Columbia – Researchers have yet again been sent back to the drawing board in the development of the much-sought-after vaccination for smokers, which would hypothetically inhibit the action of nicotine and its pleasure-producing chemical response in the brain. One of the newest studies of a proposed vaccine shows mixed results for patients after molecular imaging revealed no desirable effect and potentially allowed even more nicotine accumulation in the brain in some cases due to variations in immune response, say neuroscientists at the Society of Nuclear ...
High sugar intake linked to low dopamine release in insulin resistant patients
2013-06-11
Vancouver, British Columbia – Using positron emission tomography (PET) imaging of the brain, researchers have identified a sweet spot that operates in a disorderly way when simple sugars are introduced to people with insulin resistance, a precursor to type 2 diabetes. For those who have the metabolic syndrome, a sugar drink resulted in a lower-than-normal release of the chemical dopamine in a major pleasure center of the brain. This chemical response may be indicative of a deficient reward system, which could potentially be setting the stage for insulin resistance. This ...
Radiopeptide therapy improves survival outcomes for neuroendocrine cancer patients
2013-06-11
Vancouver, British Columbia – Peptide-receptor radionuclide therapy (PRRT) has been a subject of growing research on neuroendocrine tumors, which take up residence in a variety of organs replete with nerve cells that respond to hormone signaling. A countrywide study in Germany deemed PRRT treatment not only safe and effective but life-prolonging, according to a study unveiled during the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.
PRRT is a new and yet-to-be-approved treatment for patients with neuroendocrine tumors (NETs). These develop when ...
Molecular imaging enlists prostate enzyme to detect metastases
2013-06-11
Vancouver, British Columbia – No matter where they have hidden, metastatic prostate cancer cells still express some of the same signaling as normal prostate cells; in some cases even more so, as with the PSMA enzyme. Harnessing this enzyme could mean the beginning of a new platform for prostate cancer detection, staging, treatment and post-treatment monitoring, say researchers at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.
"There are currently no ideal imaging techniques in clinical practice that are specific to prostate cancer," said ...
Radioimmunotherapy could extend lives of advanced lymphoma patients
2013-06-11
Vancouver, British Columbia – A new patient protocol for aggressive and recurrent lymphoma that combines intensive chemotherapy and radioimmunotherapy (RIT) may become the most powerful cancer-killing therapy available, with the hope that patients' lymphoma can be eradicated as they prepare for bone marrow transplant, say researchers at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging. In a study presented at the meeting, survival rates without recurrence improved with the addition of RIT, with some having a 100 percent chance of survival ...
Breast cancer: PET and MR predict chemotherapy's ability to prolong life
2013-06-11
Vancouver, British Columbia – For patients with advanced breast cancer, positron emission tomography (PET) and magnetic resonance (MR) imaging can improve quality of life and survival by providing physicians with information on the effectiveness of chemotherapy prior to surgery, say researchers presenting at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.
Researchers combined separate imaging systems—PET, MR and CT—to map the course of chemotherapy before surgery, otherwise known as neoadjuvant chemotherapy. These different imaging systems ...
PET/MR effective for imaging recurrent prostate cancer
2013-06-11
Vancouver, British Columbia – When prostate cancer makes a comeback, it becomes increasingly important to have exceptional imaging available to find all possible regions where cancer has spread to other parts of the body, or metastasized, in order to plan the best possible treatment. A relatively new imaging system that simultaneously combines positron emission tomography and magnetic resonance (PET/MR) demonstrates a higher capacity for mapping recurrent prostate cancer than the already high standard of integrated PET and computed tomography (PET/CT), say researchers presenting ...
Hormonal treatment for endometrial cancer does not directly target the malignant cells
2013-06-11
Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, according to a study from the G.O. Discovery Lab team and collaborators at UCLA.
Like tumors of the breast and prostate, endometrial cancer is regulated by hormones. Unlike therapies for breast and prostate cancer, where drugs are given to block hormone signaling, in therapy for endometrial cancer progesterone is given to stimulate its hormone receptor. ...
Plunging fish numbers linked to dam releases
2013-06-11
A significant decline in the numbers of native fish in Australia's Murray-Darling Basin may be linked to released dam water being too cold for breeding.
This is just one of the findings from a Griffith University led study which found current water releases back into the Murray-Darling system limit fish reproduction and therefore impact freshwater biodiversity.
Griffith University Research Fellow Dr Rob Rolls said the results, published in Freshwater Biology, throw cold water on the notion that large dam releases compensate for the effects of interrupting natural water ...
Screening fails to affect breast cancer mortality statistics
2013-06-11
New research analysing breast cancer mortality data spanning almost 40 years concludes that breast cancer screening does not yet show an effect on mortality statistics. The research, published in the Journal of the Royal Society of Medicine, analysed mortality trends before and after the introduction of the National Health Service Breast Screening Programme in 1988. The research was based on an analysis of mortality statistics in the Oxford region because, unlike the rest of England, all causes of death on the death certificate, not just the underlying cause, are available ...
LAST 30 PRESS RELEASES:
Columbia University Fertility Center named #1 by Newsweek
Two prominent Boston Children's Hospital scientists elected to National Academy of Sciences
Vegetation changes accelerated climate shifts during the late Miocene, study finds
Scientists discover key to taming unrest at Italy’s Campi Flegrei
Study reveals details of process driving evolution and major diseases
NCSA director Bill Gropp honored with prestigious ACM award
The future of brain activity monitoring may look like a strand of hair
New gene-editing therapy shows early success in fighting advanced GI cancers
nTIDE May 2025 Jobs Report: Employment of People with Disabilities Remains in a Holding Pattern
SCAI honors members for outstanding service and dedication
NRG Oncology adds new committee leaders in lung cancer and imaging
Sun safety declining in Canada amid rise in skin cancer cases
Pennington Biomedical highlights how cellular quality control contribute to insulin resistance related to type 2 diabetes
ACM honors those who shape technology's future
ESE and ESPE joint event to call for stronger national and EU action on endocrine disruptors
Call for papers: Commemorative collection honoring Dr. Judith Campisi
New studies highlight potential of artificial intelligence to improve outcomes for patients with heart failure and cardiac arrest
Space junk falling to Earth needs to be tracked. Meteoroid sounds can help
Dust in the system — How Saharan storms threaten Europe’s solar power future
“It’s like they have a superpower”: Genetic analysis of all-women extreme divers finds changes linked to blood pressure, cold tolerance
The all-female Korean Haenyeo divers show genetic adaptions to cold water diving
Antivenom neutralizes the neurotoxins of 19 of the world’s deadliest snakes
Postpartum care differences in LGBTQ+ and non-LGBTQ+ individuals
Medicaid unwinding linked to disruptions in opioid addiction treatment
State-level tax policy, cancer screening, and mortality rates in the US
Lactate mediates training of our innate defenses
Sutter Health study highlights the power and potential of ambient AI to improve clinician well-being
How mid-Cretaceous events affected marine top predators
How will 13 million farmers fight back against sea level rise? New global model simulates adaptation, migration, and survival in the face of climate crises
PSU study gauges public's willingness on microplastic interventions
[Press-News.org] Pre-Alzheimer's: Metabolic disorder found in cognitively normal patientsHealthy test subjects with amyloid plaque were also found to have hypometabolism indicating a potential Alzheimer's precursor